Combination chemotherapy with paclitaxel, cisplatin and fluorouracil for patients with advanced and metastatic gastric or esophagogastric junction adenocarcinoma: a multicenter prospective study

OBJECTIVE: To evaluate the efficacy and toxicity of the combination regimen of paclitaxel, cisplatin and 5-FU (PCF) as first-line or second-line therapy in patients with advanced gastric and esophagogastric junction (EGJ) adenocarcinoma in China. METHODS: The patients were treated with paclitaxel 15...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Zhang, Xiao-Dong, Shu, Yong-Qian, Liang, Jun, Zhang, Feng-Chun, Ma, Xue-Zhen, Huang, Jian-Jin, Chen, Li, Shi, Gen-Ming, Cao, Wei-Guo, Guo, Cheng-Ye, Shen, Lin, Jin, Mao-Lin
Format: Artigo
Idioma:Inglês
Publicat: Chinese Journal of Cancer Research Limited Company 2012
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3551331/
https://ncbi.nlm.nih.gov/pubmed/23359329
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3978/j.issn.1000-9604.2012.08.04
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars